Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?-Reference-Cited by-同舟云学术

Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?

Published:2014-01-15 Issue:3 Volume:164 Page:396-408
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Balduzzi Adriana¹,Di Maio Lucia¹,Silvestri Daniela¹²,Songia Simona³,Bonanomi Sonia¹,Rovelli Attilio¹,Conter Valentino¹,Biondi Andrea¹³,Cazzaniga Giovanni³,Valsecchi Maria G.²

Affiliation:

1. Clinica Pediatrica; Università degli Studi di Milano-Bicocca; Ospedale San Gerardo; Monza Italy

2. Dipartimento di Scienze della Salute; Centro di Ricerca in Biostatistica per l'Epidemiologia Clinica; Università degli Studi di Milano-Bicocca; Monza Italy

3. Centro Ricerca Tettamanti; Clinica Pediatrica; Università degli Studi di Milano-Bicocca; Monza Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12639/fullpdf

Reference56 articles.

1. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL;Bader;Leukemia,2002

2. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?;Bader;Journal of Clinical Oncology,2004

3. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group;Bader;Journal of Clinical Oncology,2009

4. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study;Balduzzi;Lancet,2005

5. Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL;Balduzzi;Bone Marrow Transplantation,2011a

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I use next-generation sequencing–MRD to plan approach and prevent relapse after HCT for children and adults with ALL;Blood;2024-07-18

2. Risk factors for positive post-transplantation measurable residual disease in patients with acute lymphoblastic leukemia;Chinese Medical Journal;2024-07-09

3. CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia;Heliyon;2024-07

4. Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients;Transplantation and Cellular Therapy;2024-07

5. Superior Survival with Allogeneic Hematopoietic Stem Cell Transplantation versus Chemotherapy for High-Risk Adult Acute Lymphoblastic Leukemia in PDT-ALL-2016 Pediatric-Inspired Cohort;2024-03-07